Bortezomib

Details:

Bortezomib / 179324-69-7 China ShengDa Pharmaceutical Company offers Bortezomib / 179324-69-7. and intermediates for your evaluation, Please visit: www dot abroadtrade dot com.and write email to:lance755 # hotmail dot com. we product Anti-biotics Series(meropenem, biapenem etc.) antineoplastics(Naloxone HCl/357-08-4., etc.)and Anti-aids Series(ritonavir, lopinavir Maraviroc, raltegravir). Anti-Cancer(Epirubicin HCl, Idarubicin HCl, Paclitaxel And Docetaxel,Capecitabine, Gemcitabine HCl, Teniposide, Etoposide, Estramustine,Sitagliptin Phosphate/654671-77-9,Phosphate Sodium, Imatinib mesylate / 220127-57-1, Dasatinib/863127-77-9,Sunitinib malate/341031-54-7, Gefitinib / 184475-35-2,Erlotinib HCl / 183319-69-9, sorafenib tosylate 284461-73-0 / 4750207-59-1, Lelrozol/112809-51-5,Entecavir / 142217-69-4,Pazopanib / 444731-52-6,Vandetanib / 443913-73-3,valrubicin / 56124-62-0,Irinotecan HCL Trihydrate / 136572-09-3 ,Rocuronium Bromide / 119302-91-9,Bortezomib / 179324-69-7 Ivabradine HCl / 148849-67-6 and so on Offer Bortezomib / 179324-69-7 Appearance: White or off-white crystalline powder Complies Original:China ShengDa Pharmaceutical Company Identification: (by NMR) The Nuclear Magnetic Resonance spectrum of the sample should be the same that of reference material Positive Loss on drying: ≤0.5% 0.1% Burned ash: ≤0.1% 0.08% Heavy Metals: ≤20ppm Complies Assay(HPLC): ≥98.5% 99.1%